Tara Clarke: Pfizer Inc. (NYSE:PFE) will soon feel the pressure from the wave of lawsuits being filed claiming that Pfizer’s blockbuster drug Lipitor – the world’s best-selling drug of all time – causes type-2 diabetes in women. With a market ...
Meanwhile, Dow component Pfizer Inc. (NYSE:PFE) helped boost the blue-chip index higher after ... at 17,832.03; the …
In after hours trade shares of Pfizer were up 1.4% following the announcement. Pfizer is set to announce third quarter results on Tuesday, October 28 before the market open. Get the latest Pfizer stock price here.
Shares of Pfizer Inc. closed the previous trading session at with 35.77000045776367 shares trading hands. The post Insider Trading Activity Pfizer Inc. (NYSE:PFE) – Insider Sold 13,986 shares of Stock appeared first on Market Exclusive.
Diane Alter: The Pfizer stock price is up 0.5% today as the U.S. drug giant remains in advanced stages to buy Allergan Plc. (NYSE:AGN). Pfizer Inc. (NYSE:PFE) is pushing forward with the deal despite the best wishes of the U.S. …
Pfizer (NYSE: PFE) positive top-line results of a Phase 2 study of TRUMENBA (Meningococcal Group B Vaccine) co-administered with FDA-approved, routine meningococcal (groups A, C, Y and W) (MCV4) and single-dose tetanus, …
Pfizer Inc. (NYSE:PFE) is expected to focus on the development of new ... likely speeding up its final testing and …
Pfizer (NYSE: PFE) announced today top-line results from a double-blind Phase 3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (pain after shingles or PHN). The results show that …